Where the Street stands
These are third-party analyst opinions from named firms, not advice, and not a prediction. How we score this
23 firms currently rating it, weighted by track record.
The 23 firms with a track record here beat the S&P 44% of the time over 12 months.
Pro: see the crowd-vs-sharp split for ARMAnalysts rate ARM a consensus Buy, with 27 of 37 covering firms rating buy or stronger. The average price target stands at $286.79, implying 1.5% upside from current levels, though targets range from $125.00 to $500.00. Most recent rating actions in late July maintained positions: Rosenblatt, UBS, TD Cowen, Wells Fargo, Guggenheim, and Needham held Buy or equivalent ratings, while Morgan Stanley maintained Equal-Weight. ARM trades at a trailing P/E of 285.42 with a forward P/E of 92.06, supported by 22.4% revenue growth and 108.3% EPS growth year-over-year, alongside a fortress balance sheet with 0.06 debt-to-equity ratio. The stock carries high volatility at a beta of 3.91 and has traded between $100.02 and $452.70 over the past 52 weeks.
Generated from the data on this page; may contain errors. Analyst opinions belong to the named firms. Informational only, not investment advice.
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 31, 2026 | Rosenblatt | ○ Maintained | |
| Jul 30, 2026 | UBS | ○ Maintained |
Create a free account to unlock all analyst ratings, key stats, and news. No credit card, takes 30 seconds.
Sign up free